More about
Virus-Related Hepatocellular Carcinoma
CME
Podcast
Optimizing the Use of Ethiodized Oil in Interventional Radiology: A Podcast Series
This activity is supported by an educational grant from Guerbet LLC.
News
November 14, 2023
2 min read
Save
Direct-acting antiviral use remains low, despite improved survival in HCV-related HCC
BOSTON — Direct-acting antiviral therapy for hepatitis C virus-related hepatocellular carcinoma significantly improves overall survival, but only one in four patients receive therapy, even with insurance, according to a researcher.